James J. Vaughn is CCO at GENOMIC HEALTH INC (GHDX). They have made 7 open-market trades across 1 company since 2017, most recently 2019-09-09.
CIK 0001649689
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GHDX | 16,617 | $1.1M |
Shares reported on the most recent Form 4, priced at the 2019-09-11 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GHDX | SELL | 2019-09-09 | 2019-09-11 | $72.50 | $326K | -2.8% | -6.1% | N/A |
| GHDX | SELL | 2019-08-08 | 2019-08-12 | $73.74 | $332K | +0.7% | -0.0% | N/A |
| GHDX | SELL | 2019-06-06 | 2019-06-10 | $52.47 | $459K | +5.4% | +10.9% | +37.1% |
| GHDX | SELL | 2019-05-08 | 2019-05-10 | $58.08 | $421K | -2.2% | -8.1% | +31.7% |
| GHDX | SELL | 2018-10-08 | 2018-10-10 | $64.86 | $3.2M | +6.0% | +31.5% | +9.4% |
| GHDX | SELL | 2018-06-04 | 2018-06-06 | $45.78 | $4.3M | +0.9% | +1.8% | +26.4% |
| GHDX | SELL | 2017-11-01 | 2017-11-08 | $32.57 | $228K | -1.9% | +2.1% | +11.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.